Status:
COMPLETED
Observational Study of iv Ibandronate in Women With Postmenopausal Osteoporosis
Lead Sponsor:
Clinic of Endocrinology and Metabolic Disorders, Macedonia
Collaborating Sponsors:
Clinic for Orthopedic Surgery, Skopje
General Hospital, Kumanovo
Conditions:
Osteoporosis
Eligibility:
FEMALE
18+ years
Brief Summary
This observational study assess the safety of intravenous Ibandronate (Bonviva) intermittent administration in patients with postmenopausal osteoporosis and the efficacy of IV Ibandronate (Bonviva tre...
Eligibility Criteria
Inclusion
- Patients had post menopausal osteoporosis
- Patients had no contraindication for bisphosphonates
- Patients had been naive for ibandronate therapy
- Patients who have signed informed consent and are willing to share their data for data analysis
Exclusion
- Is not Ibandronate naïve
- Hypersensitivity to any component of the bisphosphonates Ibandronate;
- Administration of any investigational drug within 30 days preceding the first dose of the study drug.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT02271204
Start Date
March 1 2009
End Date
April 1 2014
Last Update
October 22 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.